Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Inventurus Knowledge Solutions Limited ( (IN:IKS) ).
The company posted Q3 FY26 revenue of INR 8,150 million, up 24% year on year, with EBITDA rising 40% and PAT climbing 41%, reflecting sustained expansion across existing and newly won provider clients. Management highlighted that tightened U.S. physician margins are accelerating adoption of IKS’s platform, while ongoing AI investments and partnerships with groups like StrideCare and VitalMD aim to reinforce profitability and operational efficiency gains.
More about Inventurus Knowledge Solutions Limited
Inventurus Knowledge Solutions Limited operates in the technology-enabled healthcare solutions industry, delivering care enablement and outsourcing services for U.S. physician enterprises through its integrated platform and AI-enhanced patient engagement suite.
Average Trading Volume: 13,214
Technical Sentiment Signal: Buy
Current Market Cap: 267.8B INR
Learn more about IKS stock on TipRanks’ Stock Analysis page.